Pfizer Subsidiaries Agree to Pay $60.2 Million to Settle Civil and Criminal FCPA Charges

The DOJ announced on August 7, 2012 that Pfizer H.C.P., a subsidiary of Pfizer Inc., has agreed to pay $15 million to resolve FCPA violations arising out of conduct in various countries in Europe and Asia.  The Pfizer subsidiary has also agreed to pay $26.3 million in disgorgement of profits and pre-judgment interest to settle SEC charges; Wyeth LLC, a company Pfizer bought three years ago, agreed to pay $18.9 million in disgorgement and pre-judgment interest.  Pfizer reported in a November 2011 SEC filing that it had reached an agreement in principle with the government, but the details were not announced until nine months later.

To read the full article

Continue reading your article with an ACR subscription.